Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer

BACKGROUND: No consensus exists on the outcome-related factors of interval debulking surgery (IDS) in patients with advanced high-grade serous ovarian cancer (HG-SOC) who underwent neoadjuvant chemotherapy (NAC). This study aimed to explore the optimal timing for IDS and the prognosis-associated fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xia, Deng, Fei, Lv, Mengmeng, Ren, Binhui, Guo, Wenwen, Chen, Xiaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134071/
https://www.ncbi.nlm.nih.gov/pubmed/27912779
http://dx.doi.org/10.1186/s13048-016-0294-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134071/
https://www.ncbi.nlm.nih.gov/pubmed/27912779
http://dx.doi.org/10.1186/s13048-016-0294-z

Ejemplares similares